← Back to Clinical Trials
Recruiting NCT06105853

NCT06105853 Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06105853
Status Recruiting
Phase
Sponsor Central Institute of Mental Health, Mannheim
Condition Alcohol Use Disorder
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2023-12-01
Primary Completion 2027-06-30

Trial Parameters

Condition Alcohol Use Disorder
Sponsor Central Institute of Mental Health, Mannheim
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2023-12-01
Completion 2027-06-30
Interventions
Trier Social Stress TestBarlab Cue-ExposureFunctional magnetic resonance imaging

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational study is to investigate longitudinal stress response profiles and adaptive versus non-adaptive stress responses in alcohol use disorder. The main questions the projects aims to answer are: What are the neurobehavioral underpinnings of adaptive stress responses and resilience to repeated stress exposure with regards to: * alcohol craving? * alcohol use? * their modulation by prior stress exposure, social interactions, coping strategies and individual health behavior? Participants will: * be exposed to an established experimental stress-induction protocol, the Trier Social Stress Test * be exposed to their favorite drink in a bar lab environment * be assessed using fMRI to determine their neural alcohol cue reactivity, response inhibition, and emotion processing * conduct an ambulatory phase to assess stressors, alcohol craving, substance use and details on social interactions, health behavior and coping strategies using ecological momentary assessment tools.

Eligibility Criteria

Inclusion criteria are: * age between 16 and 65 years * meeting at least 2 criteria of an alcohol use disorder according to the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5), yet without the need for a therapeutic intervention * fluency in German * able to understand the study procedures and give informed consent * willingness to use a study smartphone Exclusion criteria are: * current use of drugs or medications that interact with the central nervous system or the glucocorticoid system * contraindications for magnetic resonance imaging * medical history of bipolar disorder, psychotic disorder, schizophrenia or schizophrenic spectrum disorder, or substance use disorder other than alcohol, nicotine, or cannabis * medical history of severe head injury or other severe central nervous system disorders or other severe somatic disorders (e.g. liver cirrhosis) * pregnancy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology